Publications

Sickle Cell Disease (SCD) is a hereditary hemoglobinopathy characterized by chronic hemolytic anemia and vaso-occlusiveevents. In recent years, the Neutrophil-to-Lymphocyte Ratio (NLR) has emerged as a potential biomarker with prognostic anddiagnostic significance in various medical conditions. This review explores the clinical implications of NLR in the context of SCD,shedding light on its role as a valuable indicator of inflammation, disease severity, and treatment response. The inflammatorystate is a key contributor to the pathophysiology of SCD, influencing disease progression and complications. NLR, calculatedfrom routine complete blood counts, reflects the balance between the immune response’s cellular components and has beenimplicated in assessing the inflammatory status in various diseases. In the context of SCD, elevated NLR has been associatedwith increased vaso-occlusive events, suggesting its potential utility as a predictive marker for disease complications. Inconclusion, this perspective review consolidates current knowledge on the clinical implications of NLR in Sickle Cell Disease.It highlights the potential of NLR as a readily available and cost-effective biomarker for assessing inflammation, predictingdisease severity, and monitoring treatment response in individuals with SCD. As the understanding of the immunologicalaspects of SCD continues to evolve, NLR stands out as a promising parameter that may contribute to a more comprehensiveapproach to managing this complex hematologic disorder.